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Conclusions: With the large-scale population use of aspirin 
for cardiovascular prophylaxis and other benefits, the poten-
tial risks to hearing health should be considered, particularly 
given that the effects may be reversible or improved with 
altered dosing. With the increasing prevalence of hearing loss 
in all age groups and segments of the population, attention to 
widespread exposures of risk may help preserve hearing-
related health.
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Objectives: Evaluate the role of endoscopic approaches dur-
ing exclusive or combined (microscopic and endoscopic) pro-
cedures to stapedial region, particularly in difficult cases or in 
anatomic abnormalities.
Methods: From 2009 to 2014, 56 endoscopic exclusive or 
combined (microscopic and endoscopic) approaches to the 
stapedial region were performed at the otolaryngology depart-
ment, University Hospital of Modena. Operations performed 
were stapedoplasties or explorative tympanotomies for con-
ductive hearing loss. Video, patient charts, and operative 
reports from surgeries were reviewed in February 2014. Cases 
in which stapedial abnormalities were identified were included 
and analyzed in the present study.
Results: In 8 cases a malformed stapes was identified. Of 
those, 6 were eventually treated, while in 2 cases, after a diag-
nosis was made, a conservative attitude was chosen. Under 
endoscopic view, precise procedures under direct view were 
made possible, even in very delicate and hidden regions.
Conclusions: Whether chosen as a pure explorative tool, or as 
the main operatory visualization modality, endoscopy can guar-
antee very good visualization of the stapedial region, and may 
help in diagnosing and fixing altered stapedial conditions.
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Objectives: Enlarged vestibular aqueduct (EVA) is the most 
common inner ear malformation. While a strong correlative 
relationship between EVA and hearing loss exists, its associa-
tion with vestibular dysfunction is less well established. In 
this study, we characterize the vestibular phenotype in patients 
with EVA.
Methods: This was a prospective, cross-sectional study of 
106 patients with unilateral (n = 26) or bilateral (n = 80) EVA, 
defined as a midpoint diameter greater than 1.5 mm, who were 
referred or self-referred to participate in a study of the clinical 
and molecular analysis of EVA at the National Institutes of 
Health. We obtained a clinical history focused on vestibular 
dysfunction, and specifically asked about age of independent 
walking, history of vertigo, head tilt with vomiting, and clum-
siness. Based on tolerance and availability, participants under-
went videonystagmography (VNG), cervical vestibular 
evoked myogenic potentials (cVEMP), and rotary vestibular 
chair testing (RVT) to objectively assess their vestibular 
function.
Results: Forty-five percent of patients with EVA reported 
vestibular symptoms. A total of 44% (28 out of 66) of those 
completing VNG testing had abnormal results, as defined by 
abnormalities in caloric, ocular motor, and positional testing. 
An increased number of vestibular symptoms is correlated 
with the presence of bilateral (rather than unilateral) EVA (P = 
.008) and a history of head injury (P < .001). Abnormal VNG 
results also correlated with a history of head injury (P = .01).
Conclusions: Vestibular dysfunction is common in patients 
with EVA. To our knowledge, this is one of the largest pro-
spective EVA studies which specifically address the vestibular 
manifestations.
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Objectives: (1) Describe data on comprehensive vestibular 
testing in migraine-associated vertigo patients. (2) Delineate 
specific findings in vestibular testing that can assist in the 
diagnosis and treatment of migraine-associated vertigo.
Methods: A retrospective case review of individuals diag-
nosed with migraine-associated vertigo after evaluation by an 
otologist, a neurologist, and who had vestibular testing 
between January 1, 2010, and June 31, 2012, at a tertiary 
referral center. Videonystagmography (VNG), sinusoidal har-
monic acceleration (SHA) testing, and cervical vestibular 
evoked myogenic potential (cVEMP) testing were analyzed.
Results: Eighty-three patients met inclusion criteria; 63 had 
a diagnosis of primary migraine-associated vertigo. An addi-
tional 20 patients had a secondary diagnosis including 
Ménières disease, intracranial hypertension, and a history of 
cranial surgery (secondary migraine-associated vertigo). The 
average patient was 49 years old, with 82% being female. 
There was no statistically significant difference between the 2 
groups. Overall, 30% of migraine-associated vertigo patients 
had abnormal caloric testing with a 60% average unilateral 
weakness. The unilateral weakness was to the right 77% of the 
time. When VNG, SHA, and cVEMP testing were combined, 
24 patients (29%) had an identifiable vestibular weakness; 
75% had a peripheral source and 25% had central vestibular 
findings. A total of 50% of patients with a peripheral weakness 
were fully compensated, 33% were partially compensated, 
and 17% were poorly compensated.
Conclusions: In patients with primary and secondary migraine-
associated vertigo, approximately two-thirds of patients were 
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